Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-02-13 16:13:47
Reporting Period:
Filing Date:
Accepted Time:
2017-02-13 16:13:47
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352453 Andrew Blight 420 Saw Mill River Road
Ardsley NY 10502
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-09 67,586 $22.13 144,144 No 4 M Direct
Common Stock Disposition 2017-02-09 67,586 $22.41 76,558 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2017-02-09 67,586 $0.00 67,586 $22.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-02-14 No 4 M Direct
  1. Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2017 on the expiration date reported within Table II unless exercised.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $22.25 to $23.05 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The shares subject to these options vested in installments and were fully vested on 1/01/2011.